-1024x576.jpg&w=2048&q=75)
ISO 15223-1 Amendment: EC-REP Symbol Changes to EU-REP
MedNet EC-REP GmbH is pleased to announce an important update to the symbol for European Authorized Representatives. The International Organization for Standardization (ISO) has recently amended ISO 15223-1:2021, introducing a change from "EC-REP" to "EU-REP" for the European Authorized Representative symbol.
This modification aims to eliminate potential confusion with Ecuador's country code (EC) and enhance clarity in medical device labeling. The amendment, ISO 15223-1:2021/Amd 1:2025, specifies that the authorized representative in the European Union will now be identified by "EU-REP" instead of "EC-REP".
Key Points for Manufacturers:
- Gradual Transition: There is no immediate requirement to change your labels. We recommend implementing the new symbol when other label modifications become necessary
- Updated Symbol Usage: When updating your labels, please use our contact details with the new EU-REP symbol
- Notified Body Requirements: If a Notified Body is involved in your product's conformity assessment, they may have specific transition period requirements. We advise contacting them directly for guidance
This amendment reflects the ongoing efforts to streamline and clarify medical device regulations across the European Union. MedNet EC-REP GmbH remains committed to supporting our clients through this transition and ensuring compliance with the latest regulatory standards.
For any questions or concerns regarding this change, please don't hesitate to contact our team. We're here to assist you in navigating these updates and maintaining full compliance with EU regulations.
Latest news
-250x250.jpg&w=256&q=75)
MedNet EC-REP at CMEF Shanghai 2025
We are pleased to announce that we will be exhibiting at the China International Medical Equipment Fair (CMEF) in Shanghai from April 8 to April 11, 2025.

New Revision of MDCG 2020-16 Guidance on IVD Classification: Key Updates in Version 4
The Medical Device Coordination Group (MDCG) has released Revision 4 of the "Guidance on Classification Rules for in vitro Diagnostic Medical Devices under Regulation (EU) 2017/746" (MDCG 2020-16).

UK Updates Post-Market Surveillance Requirements for Medical Devices
The Medicines and Healthcare products Regulatory Agency (MHRA) has released updated guidance on post-market surveillance (PMS) requirements for medical devices in Great Britain.
%20(1)-250x250.jpg&w=256&q=75)
MedNet EC-REP at MedTec Japan 2025 – Meet Us at Booth 3303
We are pleased to announce our participation as an exhibitor at MedTec Japan 2025, one of Asia’s leading trade shows for medical device design and manufacturing. The event will take place in Tokyo from April 9–11, 2025.

Swissmedic Highlights Post-Market Surveillance Obligations for Legacy Devices
Swissmedic has released findings from a recent focused action, underscoring the critical importance of robust Post-Market Surveillance (PMS) for all medical devices.

EU Publishes Second Revision of MDCG 2023-3: Key Updates for Manufacturers
The European Commission has released the second revision of the MDCG 2023-3 guidance document in January 2025. This update includes important clarifications in line with Regulation (EU) 2024/1860

EU Commission Updates Guidance on SARS-CoV-2 Test Classification
The In Vitro Diagnostic (IVD) expert panel of the European Commission has released new scientific advice regarding SARS-CoV-2.